Indian Antimalarial Drugs Market
India Antimalarial Drugs Market Research 2024: Competitive Landscape, Key Trends, Forecast & Opportunities, 2020-2030
October 09, 2024 10:44 ET | Research and Markets
Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "India Antimalarial Drugs Market, By Region, Competition, Forecast & Opportunities, 2020-2030F" report has been added to ResearchAndMarkets.com's...
Global Artemisinin Combination Therapy Market
Global Artemisinin Combination Therapy Market (2022-2027): An Artemisinin-Based Combination of Multiple Medicines That Are Matched in Terms of Half-Life Might Be the Future of Malaria Treatment
November 23, 2023 10:13 ET | Research and Markets
Dublin, Nov. 23, 2023 (GLOBE NEWSWIRE) -- The "Global Artemisinin Combination Therapy Market (2022-2027) by Combination Therapy Type, and Geography, Competitive Analysis and the Impact of Covid-19...
22157.jpg
Global Global Antimalarial Drugs Market Research Report 2022: Increasing Prevalence of Malaria Coupled with Surge in Research for New Drugs to Propel Growth - Forecasts to 2028
February 17, 2023 06:48 ET | Research and Markets
Dublin, Feb. 17, 2023 (GLOBE NEWSWIRE) -- The "Global Antimalarial Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Drug Type, By Drug Class, By...
Manus_Bio_logo_1112018_gc.jpg
Manus Bio Awarded Additional Funding to Support its Artemisinin Development Program
April 01, 2021 10:38 ET | Manus Bio
CAMBRIDGE, Mass., April 01, 2021 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...
MateonLogo.jpg
MATEON’S GLOBAL STUDY FOR ARTEMISININ INTERVENTION AGAINST COVID-19 CLEARED FOR PATIENT ENROLLMENT IN INDIA.
September 14, 2020 07:00 ET | Mateon Therapeutics, Inc.
AGOURA HILLS, Calif., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics “Mateon” (OTC.QB: MATN), a leading developer of TGF-β therapeutics for oncology and COVID-19, announced today that its...
MateonLogo.jpg
MATEON THERAPEUTICS AND ABIOGENESIS TO INITIATE CLINICAL STUDY TO TEST ARTEMISININ AS A TREATMENT FOR COVID-19 IN INDIA
August 04, 2020 07:00 ET | Mateon Therapeutics, Inc.
AGOURA HILLS, Calif., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics (OTCQB: MATN), a leading developer of TGF-β therapeutics, will be working together with Abiogenesis to initiate ARTI-19...
Manus_Bio_logo_1112018_gc.jpg
Manus Bio Awarded Next Stage of Funding to Continue Development of a Novel Production Method for Artemisinin
May 09, 2019 11:32 ET | Manus Bio
CAMBRIDGE, Mass., May 09, 2019 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...
Manus Bio Logo.jpg
Manus Bio Awarded Funding to Develop Novel Production Method for Artemisinin
January 11, 2018 10:51 ET | Manus Bio
CAMBRIDGE, Mass., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Manus Bio Inc. (Manus Bio), a company which produces complex natural products through advanced fermentation, announced today that it has received...